NF1-depleted ER+ breast cancers are differentially sensitive to CDK4/6 inhibitors

Journal:
Science Translational Medicine
Published:
DOI:
10.1126/scitranslmed.adq5492
Affiliations:
6
Authors:
22
Go to article
Institutions Authors Share
Baylor College of Medicine (BCM), United States of America (USA)
19.500000
19.500000
 0.89
Guardant Health, Inc., United States of America (USA)
1.500000
 0.07
UW Medicine, United States of America (USA)
1.000000
 0.05
Interested in Oncology and Carcinogenesis?